About Us
eTheRNA has developed a proprietary and integrated set of platform technologies that are overcoming the challenges facing the development of next generation mRNA therapeutics. Our platforms include mRNA construct design and optimization, proprietary lipid nanoparticles (LNP) and formulations, and in-house process engineering capabilities for mRNA drug substance manufacturing.
What We Do
Immunotherapies
Contract Manufacturing
Newsroom
eTheRNA Announces Relocation and Expansion of R&D Facility
GENT, BELGIUM, April 5, 2022 – eTheRNA immunotherapies NV (“eTheRNA”), an mRNA technology discovery and development company with a full platform of integrated capabilities, is pleased to announce the relocation of its R&D group to a new and larger site in Gent, Belgium.
Come Join Us
Visit our careers site.
WE'D LIKE TO HEAR FROM YOU
Europe
Corporate Headquarters — Galileilaan 19, 2845 Niel, Belgium
Europe
Discovery Facility — Frieda Saeystraat 1B, 3rd floor, 9052 Zwijnaarde - Gent, Belgium
North America
530 7th Avenue — Suite 902, New York, NY 10018 United States
Asia-Pacific
Unit 605-07, 6/F Wing on Center, 111 Connaught Road Central, Sheung Wan, Hong Kong
info@etherna.be
Our Mailbox
+32 3 369 17 40
Our Phone
© 2022 eTheRNA | Studio Hanswijk